1. Home
  2. TVTX vs BV Comparison

TVTX vs BV Comparison

Compare TVTX & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • BV
  • Stock Information
  • Founded
  • TVTX 2008
  • BV 1939
  • Country
  • TVTX United States
  • BV United States
  • Employees
  • TVTX N/A
  • BV N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • BV Business Services
  • Sector
  • TVTX Health Care
  • BV Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • BV Nasdaq
  • Market Cap
  • TVTX 1.5B
  • BV 1.6B
  • IPO Year
  • TVTX N/A
  • BV 2018
  • Fundamental
  • Price
  • TVTX $18.37
  • BV $15.91
  • Analyst Decision
  • TVTX Buy
  • BV Buy
  • Analyst Count
  • TVTX 12
  • BV 8
  • Target Price
  • TVTX $24.58
  • BV $17.41
  • AVG Volume (30 Days)
  • TVTX 1.2M
  • BV 458.3K
  • Earning Date
  • TVTX 02-13-2025
  • BV 01-29-2025
  • Dividend Yield
  • TVTX N/A
  • BV N/A
  • EPS Growth
  • TVTX N/A
  • BV N/A
  • EPS
  • TVTX N/A
  • BV 0.20
  • Revenue
  • TVTX $203,447,000.00
  • BV $2,767,100,000.00
  • Revenue This Year
  • TVTX $62.38
  • BV $3.94
  • Revenue Next Year
  • TVTX $57.65
  • BV $3.55
  • P/E Ratio
  • TVTX N/A
  • BV $79.90
  • Revenue Growth
  • TVTX 57.08
  • BV N/A
  • 52 Week Low
  • TVTX $5.12
  • BV $8.12
  • 52 Week High
  • TVTX $20.33
  • BV $18.89
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 52.05
  • BV 50.81
  • Support Level
  • TVTX $16.80
  • BV $14.72
  • Resistance Level
  • TVTX $18.76
  • BV $16.39
  • Average True Range (ATR)
  • TVTX 0.90
  • BV 0.48
  • MACD
  • TVTX 0.02
  • BV 0.06
  • Stochastic Oscillator
  • TVTX 61.57
  • BV 82.63

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature, and the Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

Share on Social Networks: